Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Bioregulatory medicine improved the dog's health and recovery from chemotherapy side effects.

Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Botanical lotion CG428 may help regrow hair and reduce scalp inflammation in chemotherapy patients.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Mitotane changes steroid breakdown, affecting cortisol availability.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Minoxidil improves hair loss in breast cancer patients on CDK4/6-inhibitor therapy.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Mild oxidative stress can prevent hair loss from chemotherapy.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

A woman regrew her hair after receiving injections of special cell-derived vesicles.